查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439419

全球人工血管器材市場：洞察、競爭格局、市場預測：2030 年

Vascular Grafts Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2023年全球人工血管器材市場規模為27.3億美元。預計到 2030 年，該市場將達到 39.6 億美元，2024 年至 2030 年的預測期間複合年增長率為 6.38%。高血壓、糖尿病等生活型態相關疾病的盛行率不斷上升，是主動脈瘤、週邊動脈疾病等心血管疾病發生的主要危險因素，人口老化程度不斷加劇，其中年齡本身起著重要作用產品開發中的技術創新（例如功能改進的塗層血管移植裝置的製造）等因素預計將推動血管移植裝置市場的發展。

推動血管移植裝置市場的關鍵因素之一是由於腎衰竭發生率的增加而導致透析手術數量的增加。導致腎衰竭的重要因素之一是糖尿病。根據國際糖尿病聯盟（International Diabetes Federation）引用的數據，到2022年，全球20歲至79歲的成年人將有5.37億患有糖尿病。預計到 2045 年，這一數字將增加至 7.83 億。糖尿病與腎衰竭有關，因為高血糖會損害腎臟血管，降低其過濾血液的能力。這最終導致進行性腎衰竭，而透析是這些患者替代腎功能的唯一方法。儘管動靜脈瘺管是這些患者的首選血管通路，但它並不總是實用的選擇。因此，AV 移植物與其他血液透析通路移植物結合使用，以確保透析通路。因此，由於糖尿病患者數量增加而導致腎衰竭盛行率增加，正在推動預測期內血管移植器械市場的成長。

該報告研究了全球血管血管裝置市場，並提供了市場概述，包括按產品類型、類型、材料、最終用戶、地區和參與市場的公司概況劃分的趨勢。

目錄

第一章人工血管裝置市場報告簡介

第二章人工血管裝置市場執行摘要

第三章 監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章血管移植器械市場主要因素分析

  • 血管移植器械市場的驅動因素
  • 人工血管器械市場的限制與挑戰
  • 人工血管裝置市場機會

第五章人工血管裝置市場的波特五力分析

第六章 COVID-19 對人工血管器械市場的影響分析

第七章 人工血管器材市場概況

  • 按產品類型
  • 按類型
  • 按材質
  • 按最終用戶
  • 按地區

第八章全球人工血管器械市場公司份額分析－3至5家主要公司

第九章人工血管器械市場公司及產品概況

  • BD
  • Getinge AB
  • Medtronic
  • B. Braun Melsungen AG
  • Cardinal Health
  • Terumo Corporation
  • Terumo Corporation
  • W. L. Gore & Associates, Inc
  • JOTEC GmbH
  • LeMaitre Vascular, Inc.
  • Perouse Medical
  • CryoLife, Inc
  • BIOVIC Sdn Bhd
  • Abbott
  • Bentley
  • BioIntegral Surgical,
  • Cook
  • Merit Medical Systems
  • SCITECH
  • Vascular Graft Solutions

第10章 KOL觀點

第十一章專案方法

第 12 章. 關於 DelveInsight

第十三章 免責聲明與聯絡我們

Product Code: DIMDCL0219

Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2030 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis

Global vascular graft devices market was valued at USD 2.73 billion in 2023, growing at a CAGR of 6.38% during the forecast period from 2024 to 2030 to reach USD 3.96 billion by 2030. Factors such as the rising prevalence of lifestyle disorders such as hypertension and diabetes which present themselves as major risk factors for the development of cardiovascular diseases such as aortic aneurysms and peripheral artery disease, growing geriatric population base where age itself plays a major role in disease etiology, and technical innovation in product development such as manufacture of coated vascular graft devices with improved features among other factors are expected to drive the vascular graft devices market.

Vascular Graft Devices Market Dynamics:

One of the key aspects driving the vascular graft devices market is the growing number of dialysis procedures due to increasing incidence of kidney failure. One of the prominent contributors leading to kidney failure is diabetes. As per the data quoted by the International Diabetes Federation, in 2022, 537 million adults worldwide in the 20-79 years age group were living with diabetes. This number is predicted to rise to 783 million by 2045. Diabetes is associated with kidney failure as high blood sugar leads to damage to blood vessels in the kidneys leading to compromised filtration of blood. This ultimately leads to progressive stages of kidney failure wherein dialysis is the only way to substitute for kidney function in such patients. Even though arteriovenous (AV) fistula is the choice of vascular access in such patients, it is not always a practical choice. Therefore, AV grafts along with other hemodialysis access grafts are used to create access for dialysis. Therefore, the increasing prevalence of kidney failure due to increasing diabetic patient population are driving the growth of the vascular graft devices market during the forecast period.

Another key factor in boosting the demand for vascular grafts is the increasing cases of aortic aneurysms. Abdominal aortic aneurysm is one of the common types of aneurysm that has been reported to affect significant section of population. One of the major risk factors linked with abdominal aortic aneurysm (AAA) is smoking. According to the World Health Organization (WHO) (2023), tobacco consumption kills nearly 8 million people each year across the globe. The source further stated over 7 million of those deaths are related to direct tobacco use while around 1.2 million are related to second-hand exposure of non-smokers. Smoking has been associated with weakening of the aortic walls ultimately increasing the risk of aortic aneurysm and rupture. Furthermore, atherosclerosis has also been linked to increased risk of AAA. One of the most popular approaches of treating AAA is the endovascular aneurysm repair (EVAR) repair approach wherein endovascular stent grafts such as abdominal stent grafts are employed. Thus, the increasing prevalence of aortic aneurysms due to growing population of smokers are expected to result in growing demand for endovascular stent grafts eventually driving the vascular grafts market growth in the coming years.

However, specific limitations associated with each type of vascular grafts, and probable procedural risks and product recalls may hinder the vascular grafts market growth.

The vascular grafts market saw a decline in sales due to the implementation of measures to curb the global spread of COVID19 infection. One of the key steps during the COVID surge was numerous selective treatments and suspension of outpatient consultations. This reduced the demand for such grafts in the market as healthcare system guidelines around the world were modified to temporarily focus on managing patients exposed to COVID-19 infection. Declining product demand was observed in the vascular graft market as supply chains and product manufacturing activities were affected around the world during the lockdown phase in 2020. However, the market seems to be in the process of recovery, with the global supply chain recovering and medical facility activity resuming, providing a positive outlook for the vascular graft devices market during the forecast period.

Sales in the vascular graft devices market declined due to the implementation of measures to curb the worldwide spread of COVID-19 infection. One of the most important steps during the COVID-19 pandemic was the halt in selective treatments and interruptions in outpatient visits. This reduced the market demand for such devices as the global healthcare system modified their work flow to accommodate the patient loaf associated with the COVID-19 infection. The product demand in the vascular grafts market witnessed a stunted growth during the 2020 lockdown period. However, with the recovery of the global supply chain and the medical resumption of institutional activities, the market appears to be in the process of recovery, providing a positive outlook for the vascular grafts market over the forecast period.

Vascular Graft Devices Market Segment Analysis:

Vascular Graft Devices Market by Product Type (Endovascular Grafts [Abdominal and Thoracic], Access Grafts, Peripheral Grafts, and Others), by Type (Knitted, Woven, and Others), by Material (Synthetic [Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, and Others), by End User (Hospitals, Ambulatory Surgical Centers, and Others), by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the material segment of the vascular grafts market, the polytetrafluororthylene (PTFE) subcategory is estimated to account for a significant revenue share in the forecast period. PFTE grafts are comparatively less prone to infection and thrombosis, exhibit increased porosity, better adhesion and improved pliability in comparison with other grafts. Moreover, the development of expanded PTFE (ePTFE) has also added to growth of this product category.

Therefore, considering the advantages associated with the PTFE-based vascular grafts, this category is expected to account for a formidable market share in the vascular grafts market.

North America is expected to dominate the overall Vascular Graft Devices Market:

Among all the regions, North America is expected to account for the significant market share in the vascular graft devices market. North America is estimated to account for the dominant market share because of the increasing prevalence of cardiovascular disorders such as peripheral artery disease and aortic aneurysms, increasing prevalence of lifestyle disorders, surging geriatric population along with growing focus on product development activities in the region.

Increasing prevalence of lifestyle diseases such as hypertension and diabetes is also thought to be a major factor in the increase in the number of cases of atherosclerosis which is associated with a variety of cardiovascular diseases. According to data from the Centers for Disease Control and Prevention (2023), about 116 million people in the United States had high blood pressure in 2018. In addition, data reported in the CDC's National Diabetes Report in 2020 showed that 34.2 million Americans had diabetes and nearly 88 million American adults had pre-diabetes levels. Both hypertension and diabetes are considered to be one of the most important risk factors for developing atherosclerosis resulting in an increased risk of aortic aneurysm and other cardiovascular diseases such as peripheral artery disease.

Therefore, the presence of a large population of patients suffering from hypertension and diabetes correlates with the presence of a large population of patients suffering from heart disease such as atherosclerosis, increasing the need for vascular grafts. Thus, this trend is expected to drive the growth of the United States vascular graft market as a whole during the forecast period, as well as the growth of the entire North America vascular graft market.

Furthermore, extensive product development activities in the region, specifically in the United States also help in driving the product demand in the region. For instance, in August 2022, Terumo Corporation received the product approval from the US Food and Drug Administration for their Relay®Pro Thoracic Stent-Graft System to be employed in the treatment of patients with thoracic aortic aneurysms (TAA) and penetrating atherosclerotic ulcers (PAUs).

The US FDA is considered one of the most vigilant regulatory authorities in the world and product approvals from the specific authority holds special importance globally and creates goodwill for product and the manufacturing companies across the globe. Such factors are also instrumental in boosting the regional growth of the vascular grafts market.

Vascular Graft Devices Market Key Players:

Some of the key market players operating in the vascular graft devices market includes BD, Getinge AB, Medtronic, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, W. L. Gore & Associates, Inc., JOTEC GmbH, LeMaitre Vascular, Inc., Perouse Medical, CryoLife, Inc, BIOVIC Sdn Bhd, Abbott, Bentley, BioIntegral Surgical, Cook, Merit Medical Systems, SCITECH., Vascular Graft Solutions, and others.

Recent Developmental Activities in Vascular Graft Devices Market:

In October 2022, Terumo Aortic obtained the regulatory approval and the commercial launch of the Treo abdominal aortic stent graft system in Japan. The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) the Treo device as the treatment for abdominal aortic aneurysms.

In June 2020, LeMaitre Vascular, Inc acquired the business and assets of Artegraft, Inc. for USD 90.0 million, thereby gaining access to Artegraft's portfolio of biologic vascular grafts.

In March 2020, SCITECH received the regulatory approval for their product SOLARIS which is a vascular endograft aimed at treating peripheral vascular disease. The device received the CE mark.

Key Takeaways from the Vascular Graft Devices Market Report Study

Market analysis for current vascular graft devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the vascular graft devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global vascular graft devices market.

Various opportunities available for the other competitor in the vascular graft devices market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current vascular graft devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for vascular graft devices market growth in the coming future?

Target Audience who can be benefited from this Vascular Graft Devices Market Report Study

Vascular Graft Devices products providers

Research organizations and consulting companies

Vascular Graft Devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in vascular graft devices

Various End-users who want to know more about the vascular graft devices market and latest technological developments in the vascular graft devices market.

Frequently Asked Questions for Vascular Graft Devices Market:

1. What is a Vascular Graft?

Vascular grafting (also known as vascular bypass) is a surgical procedure that reconnects blood vessels to direct blood flow from one area of the body to another. It is done by using vascular grafts that serve as channels for creating alternate passage for establishing blood supply.

2. What is the market for Global Vascular Graft Devices?

Global vascular graft devices market was valued at USD 2.73 billion in 2023, growing at a CAGR of 6.38% during the forecast period from 2024 to 2030 to reach USD 3.96 billion by 2030.

3. What are the drivers for Global Vascular Graft Devices Market?

Factors such as the rising prevalence of lifestyle disorders such as hypertension and diabetes which present themselves as major risk factors for the development of cardiovascular diseases such as aortic aneurysms and peripheral artery disease, growing geriatric population base where age itself plays a major role in disease etiology, and technical innovation in product development such as manufacture of coated vascular graft devices with improved features among other factors are expected to drive the vascular graft devices market.

4. Who are the key players operating in Global Vascular Graft Devices Market?

Some of the key market players operating in the vascular graft devices market includes BD, Getinge AB, Medtronic, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, W. L. Gore & Associates, Inc., JOTEC GmbH, LeMaitre Vascular, Inc., Perouse Medical, CryoLife, Inc, BIOVIC Sdn Bhd, Abbott, Bentley, BioIntegral Surgical, Cook, Merit Medical Systems, SCITECH., Vascular Graft Solutions, and others.

5. Which region has the highest share in Vascular Graft Devices market?

North America is expected to account for the significant market share in the vascular graft devices market. North America is estimated to account for the dominant market share because of the increasing prevalence of cardiovascular disorders such as peripheral artery disease and aortic aneurysms, increasing prevalence of lifestyle disorders, surging geriatric population along with growing focus on product development activities in the region.

Table of Contents

1.Vascular Graft Devices Market Report Introduction

2.Vascular Graft Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Vascular Graft Devices Market Key Factor Analysis

  • 4.1. Vascular Graft Devices Market Drivers
    • 4.1.1. Rising Prevalence of Cardiovascular Diseases
    • 4.1.2. Growing Prevalence of Lifestyle Disorders
    • 4.1.3. Technical Innovation in Product Development
  • 4.2. Vascular Graft Devices Market Restraints and Challenges
    • 4.2.1. Limitations Associated with Different Vascular Grafts
    • 4.2.2. Product Recalls
  • 4.3. Vascular Graft Devices Market Opportunities
    • 4.3.1. Improving the Safety Prospects of Vascular Grafts

5. Vascular Graft Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Vascular Graft Devices Market

7. Vascular Graft Devices Market Layout

  • 7.1. By Product Type
    • 7.1.1. Endovascular Grafts
      • 7.1.1.1. Abdominal
      • 7.1.1.2. Thoracic
    • 7.1.2. Access Grafts
    • 7.1.3. Peripheral Grafts
    • 7.1.4. Others
  • 7.2. By Type
    • 7.2.1. Knitted
    • 7.2.2. Woven
    • 7.2.3. Others
  • 7.3. By Material
    • 7.3.1. Synthetic
      • 7.3.1.1. Polytetrafluoroethylene (PTFE)
      • 7.3.1.2. Polyester
      • 7.3.1.3. Polyurethane
    • 7.3.2. Biological
    • 7.3.3. Others
  • 7.4. By End User
    • 7.4.1. Hospitals
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. North America Vascular Graft Devices Market, by Product Type
      • 7.5.1.2. North America Vascular Graft Devices Market, by Type
      • 7.5.1.3. North America Vascular Graft Devices Market, by Material
      • 7.5.1.4. North America Vascular Graft Devices Market, by End User
      • 7.5.1.5. North America Vascular Graft Devices Market, by Country
      • 7.5.1.5.1. United States
      • 7.5.1.5.2. Canada
      • 7.5.1.5.3. Mexico
    • 7.5.2. Europe
      • 7.5.2.1. Europe Vascular Graft Devices Market, by Product Type
      • 7.5.2.2. Europe Vascular Graft Devices Market, by Type
      • 7.5.2.3. Europe Vascular Graft Devices Market, by Material
      • 7.5.2.4. Europe Vascular Graft Devices Market, by End User
      • 7.5.2.5. Europe Vascular Graft Devices Market, by Country
      • 7.5.2.5.1. France
      • 7.5.2.5.2. Germany
      • 7.5.2.5.3. United Kingdom
      • 7.5.2.5.4. Italy
      • 7.5.2.5.5. Spain
      • 7.5.2.5.6. Russia
      • 7.5.2.5.7. Rest of Europe
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. Asia-Pacific Vascular Graft Devices Market, by Product Type
      • 7.5.3.2. Asia-Pacific Vascular Graft Devices Market, by Type
      • 7.5.3.3. Asia-Pacific Vascular Graft Devices Market, by Material
      • 7.5.3.4. Asia-Pacific Vascular Graft Devices Market, by End User
      • 7.5.3.5. Asia-Pacific Vascular Graft Devices Market, by Country
      • 7.5.3.5.1. China
      • 7.5.3.5.2. Japan
      • 7.5.3.5.3. India
      • 7.5.3.5.4. Australia
      • 7.5.3.5.5. South Korea
      • 7.5.3.5.6. Rest of Asia Pacific
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. RoW Vascular Graft Devices Market, by Product Type
      • 7.5.4.2. RoW Vascular Graft Devices Market, by Type
      • 7.5.4.3. RoW Vascular Graft Devices Market, by Material
      • 7.5.4.4. RoW Vascular Graft Devices Market, by End User
      • 7.5.4.5. RoW Vascular Graft Devices Market, by Region
      • 7.5.4.5.1. Middle East
      • 7.5.4.5.2. Africa
      • 7.5.4.5.3. South America

8. Vascular Graft Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Vascular Graft Devices Market Company and Product Profiles

  • 9.1. BD
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Getinge AB
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Medtronic
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. B. Braun Melsungen AG
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Cardinal Health
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Terumo Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Terumo Corporation
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. W. L. Gore & Associates, Inc
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. JOTEC GmbH
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. LeMaitre Vascular, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Perouse Medical
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12. CryoLife, Inc
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. BIOVIC Sdn Bhd
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Abbott
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Bentley
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. BioIntegral Surgical,
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. Cook
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. Merit Medical Systems
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. SCITECH
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Vascular Graft Solutions
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Vascular Graft Devices Market in Global (2018-2030)
  • Table 4: Vascular Graft Devices Market in Global by Product Type (2018-2030)
  • Table 5: Vascular Graft Devices Market in Global by Type (2018-2030)
  • Table 6: Vascular Graft Devices Market in Global by Material (2018-2030)
  • Table 7: Vascular Graft Devices Market in Global by End User (2018-2030)
  • Table 8: Vascular Graft Devices Market in Global by Geography (2018-2030)
  • Table 9: Vascular Graft Devices Market in North America (2018-2030)
  • Table 10: Vascular Graft Devices Market in North America by Product Type (2018-2030)
  • Table 11: Vascular Graft Devices Market in North America by Type (2018-2030)
  • Table 12: Vascular Graft Devices Market in North America by Material (2018-2030)
  • Table 13: Vascular Graft Devices Market in North America by End User (2018-2030)
  • Table 14: Vascular Graft Devices Market in North America by Country (2018-2030)
  • Table 15: Vascular Graft Devices Market in the US (2018-2030)
  • Table 16: Vascular Graft Devices Market in Canada (2018-2030)
  • Table 17: Vascular Graft Devices Market in Mexico (2018-2030)
  • Table 18: Vascular Graft Devices Market in Europe (2018-2030)
  • Table 19: Vascular Graft Devices Market in Europe by Product Type (2018-2030)
  • Table 20: Vascular Graft Devices Market in Europe by Type (2018-2030)
  • Table 21: Vascular Graft Devices Market in Europe by Material (2018-2030)
  • Table 22: Vascular Graft Devices Market in Europe by End User (2018-2030)
  • Table 23: Vascular Graft Devices Market in Europe by Country (2018-2030)
  • Table 24: Vascular Graft Devices Market in France (2018-2030)
  • Table 25: Vascular Graft Devices Market in Germany (2018-2030)
  • Table 26: Vascular Graft Devices Market in the United Kingdom (2018-2030)
  • Table 27: Vascular Graft Devices Market in Italy (2018-2030)
  • Table 28: Vascular Graft Devices Market in Spain (2018-2030)
  • Table 29: Vascular Graft Devices Market in Russia (2018-2030)
  • Table 30: Vascular Graft Devices Market in Rest of Europe (2018-2030)
  • Table 31: Vascular Graft Devices Market in APAC (2018-2030)
  • Table 32: Vascular Graft Devices Market in APAC by Product Type (2018-2030)
  • Table 33: Vascular Graft Devices Market in APAC by Type (2018-2030)
  • Table 34: Vascular Graft Devices Market in APAC by Material (2018-2030)
  • Table 35: Vascular Graft Devices Market in APAC by End User (2018-2030)
  • Table 36: Vascular Graft Devices Market in APAC by Country (2018-2030)
  • Table 37: Vascular Graft Devices Market in China (2018-2030)
  • Table 38: Vascular Graft Devices Market in Japan (2018-2030)
  • Table 39: Vascular Graft Devices Market in India (2018-2030)
  • Table 40: Vascular Graft Devices Market in Australia (2018-2030)
  • Table 41: Vascular Graft Devices Market in South Korea (2018-2030)
  • Table 42: Vascular Graft Devices Market in Rest of APAC (2018-2030)
  • Table 43: Vascular Graft Devices Market in Rest of World (2018-2030)
  • Table 44: Vascular Graft Devices Market in RoW by Product Type (2018-2030)
  • Table 45: Vascular Graft Devices Market in RoW by Type (2018-2030)
  • Table 46: Vascular Graft Devices Market in RoW by Material (2018-2030)
  • Table 47: Vascular Graft Devices Market in RoW by End User (2018-2030)
  • Table 48: Vascular Graft Devices Market in RoW by Region (2018-2030)
  • Table 49: Vascular Graft Devices Market in Middle East (2018-2030)
  • Table 50: Vascular Graft Devices Market in Africa (2018-2030)
  • Table 51: Vascular Graft Devices Market in South America (2018-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Vascular Graft Devices Market in Global (2018-2030)
  • Figure 4: Vascular Graft Devices Market in Global by Product Type (2018-2030)
  • Figure 5: Vascular Graft Devices Market in Global by Type (2018-2030)
  • Figure 6: Vascular Graft Devices Market in Global by Material (2018-2030)
  • Figure 7: Vascular Graft Devices Market in Global by End User (2018-2030)
  • Figure 8: Vascular Graft Devices Market in Global by Geography (2018-2030)
  • Figure 9: Vascular Graft Devices Market in North America (2018-2030)
  • Figure 10: Vascular Graft Devices Market in North America by Product Type (2018-2030)
  • Figure 11: Vascular Graft Devices Market in North America by Type (2018-2030)
  • Figure 12: Vascular Graft Devices Market in North America by Material (2018-2030)
  • Figure 13: Vascular Graft Devices Market in North America by End User (2018-2030)
  • Figure 14: Vascular Graft Devices Market in North America by Country (2018-2030)
  • Figure 15: Vascular Graft Devices Market in the US (2018-2030)
  • Figure 16: Vascular Graft Devices Market in Canada (2018-2030)
  • Figure 17: Vascular Graft Devices Market in Mexico (2018-2030)
  • Figure 18: Vascular Graft Devices Market in Europe (2018-2030)
  • Figure 19: Vascular Graft Devices Market in Europe by Product Type (2018-2030)
  • Figure 20: Vascular Graft Devices Market in Europe by Type (2018-2030)
  • Figure 21: Vascular Graft Devices Market in Europe by Material (2018-2030)
  • Figure 22: Vascular Graft Devices Market in Europe by End User (2018-2030)
  • Figure 23: Vascular Graft Devices Market in Europe by Country (2018-2030)
  • Figure 24: Vascular Graft Devices Market in France (2018-2030)
  • Figure 25: Vascular Graft Devices Market in Germany (2018-2030)
  • Figure 26: Vascular Graft Devices Market in the United Kingdom (2018-2030)
  • Figure 27: Vascular Graft Devices Market in Italy (2018-2030)
  • Figure 28: Vascular Graft Devices Market in Spain (2018-2030)
  • Figure 29: Vascular Graft Devices Market in Russia (2018-2030)
  • Figure 30: Vascular Graft Devices Market in Rest of Europe (2018-2030)
  • Figure 31: Vascular Graft Devices Market in APAC (2018-2030)
  • Figure 32: Vascular Graft Devices Market in APAC by Product Type (2018-2030)
  • Figure 33: Vascular Graft Devices Market in APAC by Type (2018-2030)
  • Figure 34: Vascular Graft Devices Market in APAC by Material (2018-2030)
  • Figure 35: Vascular Graft Devices Market in APAC by End User (2018-2030)
  • Figure 36: Vascular Graft Devices Market in APAC by Country (2018-2030)
  • Figure 37: Vascular Graft Devices Market in China (2018-2030)
  • Figure 38: Vascular Graft Devices Market in Japan (2018-2030)
  • Figure 39: Vascular Graft Devices Market in India (2018-2030)
  • Figure 40: Vascular Graft Devices Market in Australia (2018-2030)
  • Figure 41: Vascular Graft Devices Market in South Korea (2018-2030)
  • Figure 42: Vascular Graft Devices Market in Rest of APAC (2018-2030)
  • Figure 43: Vascular Graft Devices Market in Rest of World (2018-2030)
  • Figure 44: Vascular Graft Devices Market in RoW by Product Type (2018-2030)
  • Figure 45: Vascular Graft Devices Market in RoW by Type (2018-2030)
  • Figure 46: Vascular Graft Devices Market in RoW by Material (2018-2030)
  • Figure 47: Vascular Graft Devices Market in RoW by End User (2018-2030)
  • Figure 48: Vascular Graft Devices Market in RoW by Region (2018-2030)
  • Figure 49: Vascular Graft Devices Market in Middle East (2018-2030)
  • Figure 50: Vascular Graft Devices Market in Africa (2018-2030)
  • Figure 51: Vascular Graft Devices Market in South America (2018-2030)
  • Figure 52: Market Drivers
  • Figure 53: Market Barriers
  • Figure 54: Marker Opportunities
  • Figure 55: PORTER'S Five Force Analysis